Gold-standard of HER2 breast cancer biopsies using supervised learning based on multiple pathologist annotations

• URL: http://arxiv.org/abs/2211.04649v1
• Date: Wed, 9 Nov 2022 02:55:20 GMT
• Title: Gold-standard of HER2 breast cancer biopsies using supervised learning based on multiple pathologist annotations
• Authors: Benjam\'in Hern\'andez and Violeta Chang
• Abstract summary: This paper presents the preliminary data analysis of the annotations of three pathologists over the same set of samples obtained using 20x magnification. We evaluate the intra- and inter-expert variability achieving substantial and moderate agreement, according to Fleiss' Kappa coefficient.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Breast cancer is one of the most common cancer in women around the world. For diagnosis, pathologists evaluate biomarkers such as HER2 protein using immunohistochemistry over tissue extracted by a biopsy. Through microscopic inspection, this assessment estimates the intensity and integrity of the membrane cells' staining and scores the sample as 0, 1+, 2+, or 3+: a subjective decision that depends on the interpretation of the pathologist. This paper presents the preliminary data analysis of the annotations of three pathologists over the same set of samples obtained using 20x magnification and including $1,252$ non-overlapping biopsy patches. We evaluate the intra- and inter-expert variability achieving substantial and moderate agreement, respectively, according to Fleiss' Kappa coefficient, as a previous stage towards a generation of a HER2 breast cancer biopsy gold-standard using supervised learning from multiple pathologist annotations.

Related papers

• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Dual-path convolutional neural network using micro-FTIR imaging to predict breast cancer subtypes and biomarkers levels: estrogen receptor, progesterone receptor, HER2 and Ki67 [0.0]
  CaReNet-V2, a novel convolutional neural network, was developed to classify breast cancer vs adjacent tissue and to predict biomarkers level. The model enabled the prediction of ER, PR, and HER2 levels, where borderline values showed lower performance.
  arXiv  Detail & Related papers  (2023-10-23T17:05:53Z)
• One-dimensional convolutional neural network model for breast cancer subtypes classification and biochemical content evaluation using micro-FTIR hyperspectral images [0.0]
  This study created a 1D deep learning tool for breast cancer subtype evaluation and biochemical contribution. CaReNet-V1, a novel 1D convolutional neural network, was developed to classify breast cancer (CA) and adjacent tissue (AT) A 1D adaptation of Grad-CAM was applied to assess the biochemical impact to the classifications.
  arXiv  Detail & Related papers  (2023-10-23T16:58:34Z)
• Cancer-Net BCa-S: Breast Cancer Grade Prediction using Volumetric Deep Radiomic Features from Synthetic Correlated Diffusion Imaging [82.74877848011798]
  The prevalence of breast cancer continues to grow, affecting about 300,000 females in the United States in 2023. The gold-standard Scarff-Bloom-Richardson (SBR) grade has been shown to consistently indicate a patient's response to chemotherapy. In this paper, we study the efficacy of deep learning for breast cancer grading based on synthetic correlated diffusion (CDI$s$) imaging.
  arXiv  Detail & Related papers  (2023-04-12T15:08:34Z)
• Interpretable HER2 scoring by evaluating clinical Guidelines through a weakly supervised, constrained Deep Learning Approach [0.0]
  This paper focuses on the interpretability of HER2 scoring by a pathologist. We propose a semi-automatic, two-stage deep learning approach that directly evaluates the clinical HER2 guidelines. We achieve a performance of 0.78 in F1-score on the test set while keeping our model interpretable for the pathologist.
  arXiv  Detail & Related papers  (2022-11-17T14:28:35Z)
• A Pathologist-Informed Workflow for Classification of Prostate Glands in Histopathology [62.997667081978825]
  Pathologists diagnose and grade prostate cancer by examining tissue from needle biopsies on glass slides. Cancer's severity and risk of metastasis are determined by the Gleason grade, a score based on the organization and morphology of prostate cancer glands. This paper proposes an automated workflow that follows pathologists' textitmodus operandi, isolating and classifying multi-scale patches of individual glands.
  arXiv  Detail & Related papers  (2022-09-27T14:08:19Z)
• Moving from 2D to 3D: volumetric medical image classification for rectal cancer staging [62.346649719614]
  preoperative discrimination between T2 and T3 stages is arguably both the most challenging and clinically significant task for rectal cancer treatment. We present a volumetric convolutional neural network to accurately discriminate T2 from T3 stage rectal cancer with rectal MR volumes.
  arXiv  Detail & Related papers  (2022-09-13T07:10:14Z)
• HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization [14.8546864876007]
  HEROHE Challenge aims to automate the assessment of the HER2 status based only on hematoxylin and eosin stained tissue sample of invasive breast cancer. Methods to assess HER2 status were presented by 21 teams worldwide.
  arXiv  Detail & Related papers  (2021-11-08T13:39:41Z)
• Learned super resolution ultrasound for improved breast lesion characterization [52.77024349608834]
  Super resolution ultrasound localization microscopy enables imaging of the microvasculature at the capillary level. In this work we use a deep neural network architecture that makes effective use of signal structure to address these challenges. By leveraging our trained network, the microvasculature structure is recovered in a short time, without prior PSF knowledge, and without requiring separability of the UCAs.
  arXiv  Detail & Related papers  (2021-07-12T09:04:20Z)
• Segmentation for Classification of Screening Pancreatic Neuroendocrine Tumors [72.65802386845002]
  This work presents comprehensive results to detect in the early stage the pancreatic neuroendocrine tumors (PNETs) in abdominal CT scans. To the best of our knowledge, this task has not been studied before as a computational task. Our approach outperforms state-of-the-art segmentation networks and achieves a sensitivity of $89.47%$ at a specificity of $81.08%$.
  arXiv  Detail & Related papers  (2020-04-04T21:21:44Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.